Childhood cancers and How to make a diagnosis

Wiangnon S, Veerakul G, Nuchprayoon I, Seksarn P, Hongeng S, Krutvecho T, et al. Childhood cancer incidence and survival 2003-2005, Thailand: study from the Thai Pediatric Oncology Group. Asian Pac J Cancer Prev. 2011;12:2215-20.

The American Cancer Society medical and editorial content team. Key Statistics for Childhood Cancers [Internet]. Atlanta: American Cancer Society. 2021 [cited 2021 Feb 1]. Available from: https://www.cancer.org/cancer/cancer-in-children/key-statistics.html #references

Lanzkowsky P, Lipton JM, Fish JD. Lanzkowsky’s manual of pediatric hematology and oncology. 6th ed. London: Academic Press; 2016.

Orkin SH, Fisher DE, Ginsburg D, Look AT, Lux SE, Nathan DG. Nathan and Oski’s hematology and oncology of infancy and childhood. 8th ed. Philadelphia: Elsevier; 2015.

DiDomizio PG, Richter C. Oncology. In: Kleinman K, Mcdaniel L, Molloy M, editors. The Harriet Lane handbook. Philadelphia: Elsevier; 2021. p.546-65.

Pizzo P, Poplack D. Principles and Practice of Pediatric Oncology. 7th ed. Philadelphia: Wolters Kluwer; 2016.

Kliegman R, St. Geme JW, Blum NJ, Shah SS, Tasker RC, Wilson KM, et al. Nelson Textbook of Pediatrics. 21st ed. Philadelphia: Elsevier; 2019.

The Thai Pediatric Oncology Group. National protocol for the treatment of childhood cancers 2018. 1st ed. Bangkok; 2018.

Hunger SP, Lu X, Devidas M, Camitta BM, Gaynon PS, Winick NJ, et al. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children’s oncology group. J Clin Oncol. 2012;30:1663-9.

Gamis AS, Alonzo TA, Perentesis JP, Meshinchi S, COG Acute Myeloid Leukemia Committee. Children’s Oncology Group’s 2013 blueprint for research: acute myeloid leukemia. Pediatr Blood Cancer. 2013;60:964-71.

Zwaan CM, Kolb EA, Reinhardt D, Abrahamsson J, Adachi S, Aplenc R, et al. Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia. J Clin Oncol. 2015;33:2949-62.

Zhang L, Samad A, Pombo-de-Oliveira MS, Scelo G, Smith MT, Feusner J, et al. Global characteristics of childhood acute promyelocytic leukemia. Blood Rev. 2015;29:101-25.

Buhtoiarov IN. Pediatric lymphoma. Pediatr Rev. 2017;38:410-23.

Conneely SE, Stevens AM. Advances in Pediatric Acute Promyelocytic Leukemia. Children (Basel). 2020;7:11.

Smith MA, Altekruse SF, Adamson PC, Reaman GH, Seibel NL. Declining childhood and adolescent cancer mortality. Cancer. 2014;120:2497-506.

Bollard CM, Lim MS, Gross TG, COG Non-Hodgkin Lymphoma Committee. Children’s Oncology Group’s 2013 blueprint for research: non-Hodgkin lymphoma. Pediatr Blood Cancer. 2013;60:979-84.

Rodriguez-Galindo C, Allen CE. Langerhans cell histiocytosis. Blood. 2020;135:1319-31.

Ishii E. Hemophagocytic Lymphohistiocytosis in Children: Pathogenesis and Treatment. Front Pediatr. 2016;4:47.

Contino A, Trombatore G, Timeus F. Hemophagocytic lymphohistiocytosis in pediatric patients: a review. J Blood Disord Symptoms Treat. 2018;2:011.

Arico M, Janka G, Fischer A, Henter JI, Blanche S, Elinder G, et al. Hemophagocytic lymphohistiocytosis. Report of 122 children from the International Registry. FHL Study Group of the Histiocyte Society. Leukemia. 1996;10:197-203

Oguz MM, Sahin G, Altinel Acoglu E, Polat E, Yucel H, Celebi FZ, et al. Secondary hemophagocytic lymphohistiocytosis in pediatric patients: a single-center experience and factors that influenced patient prognosis. Pediatr Hematol Oncol. 2019;36:1-16.

Colon NC, Chung DH. Neuroblastoma. Adv Pediatr. 2011;58:297-311.

Pinto NR, Applebaum MA, Volchenboum SL, Matthay KK, London WB, Ambros PF, et al. Advances in Risk Classification and Treatment Strategies for Neuroblastoma. J Clin Oncol. 2015;33:3008-17.

National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology. Wilms tumor. 2021 [cited 2021 Feb 20]; version 1.2021. Available from: https://www.nccn.org

Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review 1975-2017[Internet]. National Cancer Institute, c2019 [updated 2020 Apr 15; cited 2021 Feb 1]. Available from: https://seer.cancer.gov/csr/1975_2017/

Rodriguez-Galindo C, Orbach DB, VanderVeen D. Retinoblastoma. Pediatr Clin North Am. 2015;62:201-23.

Roebuck DJ, Perilongo G. Hepatoblastoma: an oncological review. Pediatr Radiol. 2006;36:183-6.

Khanna R, Verma SK. Pediatric hepatocellular carcinoma. World J Gastroenterol. 2018;24:3980-99.

Lau CS, Mahendraraj K, Chamberlain RS. Hepatocellular carcinoma in the pediatric population: a population-based clinical outcomes study involving 257 patients from the Surveillance, Epidemiology, and End Result (SEER) database (1973-2011). HPB Surg. 2015;2015:670728.

Packer RJ, MacDonald TJ, Vezina G. Tumors of the Brain and spine. In: Swainman K, Ferriero D, Schor N, eds. Swaiman’s Pediatric Neurology: Principle & Practice. 5th ed. Philadelphia: Elsevier; 2012. p.1339-87.

Udaka Y, Packer R. Pediatric brain tumors. Neurol Clin. 2018;36:533-56.

Juraschka K, Taylor MD. Medulloblastoma in the age of molecular subgroups: a review. J Neurosurg Pediatr. 2019;24:353-63.

Gatta G, Botta L, Rossi S, Aareleid T, Bielska-Lasota M, Clavel J, et al. Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5--a population-based study. Lancet Oncol. 2014;15:35-47.

Cheng S, Kilday JP, Laperriere N, Janzen L, Drake J, Bouffet E, et al. Outcomes of children with central nervous system germinoma treated with multi-agent chemotherapy followed by reduced radiation. J Neurooncol. 2016;127:173-80.

Acharya S, DeWees T, Shinohara ET, Perkins SM. Long-term outcomes and late effects for childhood and young adulthood intracranial germinomas. Neuro Oncol. 2015;17:741-6.

Zacharia BE, Bruce SS, Goldstein H, Malone HR, Neugut AI, Bruce JN. Incidence, treatment, and survival of patients with craniopharyngioma in the surveillance, epidemiology, and end results program. Neuro Oncol. 2012;14:1070-8.

Müller HL. Childhood craniopharyngioma. Pituitary. 2013;16:56-67.